Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
DNA, RNA & Cells
Filter     Order     Display # 
Date Item Title Hits
01 Sep 2010 Functional Technologies Reports Positive Results of Novel Malaria Treatment Trials 21
01 Sep 2010 Cellerant Therapeutics Awarded $153 Million Contract by Biomedical Advanced Research and Development Authority (BARDA) to Develop Treatment for Acute Radiation Syndrome (ARS) 18
01 Sep 2010 Data from Mipomersen Phase 3 Trial in heFH Patients Presented at ESC 23
30 Aug 2010 Pluristem’s Placenta Derived Cells Chosen by European Commission’s Seventh Framework Program (FP7) Study for Treatment of Diastolic Heart Failure (DHF) in Type 2 Diabetic Patients 27
27 Aug 2010 Idera Pharmaceuticals Achieves Clinical Milestone Under Its Collaboration with Merck KGaA for Cancer Treatment 63
26 Aug 2010 International Stem Cell Institute Launches Major Adipose Adult Stem Cell Therapy Program-The New Frontier of Medicine is Your Fat 46
25 Aug 2010 Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial 42
24 Aug 2010 Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 61
24 Aug 2010 AVI BioPharma Announces Positive Results Against Human Pandemic H1N1 Influenza Virus in Preclinical Studies of AVI-7100 63
23 Aug 2010 Nature Medicine Publishes AVI BioPharma Preclinical Studies Demonstrating Post-Exposure Efficacy of PMOplus(TM) Oligomers Against Ebola and Marburg Viruses 47
23 Aug 2010 Alnylam and Collaborators Publish New Pre-clinical Research on Therapeutic Silencing of Parkinson's Disease Gene 64
19 Aug 2010 International Stem Cell Corporation Formalizes Stem Cell-Based Eye Care Programs into Cytovis 134
19 Aug 2010 StemCells, Inc. Reports Breakthrough Using Human Neural Stem Cells to Restore Motor Function in Chronic Spinal Cord Injury 104
18 Aug 2010 Quark Pharmaceuticals and Major Pharmaceutical Company Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002, the First siRNA Administered Systemically in Human 87
17 Aug 2010 Cryo-Cell Announces Celle(SM) Research and Development Collaboration With Department of Medicine, Monash University 11
16 Aug 2010 International Society for Cellular Therapy (ISCT) joins forces with Roche and Genzyme to launch Cell Therapy Industry Partnership 69
11 Aug 2010 NeoStem and the Schepens Eye Research Institute to Study NeoStem's VSEL Technology in Retinal Diseases 16
10 Aug 2010 FDA Approves Innovative Liver Cell Therapy for Clinical Trial in the U.S. 71
09 Aug 2010 Fibrocell Science, Inc. Submits Clinical Study Report (CSR) to U.S. Food & Drug Administration for Phase II/III Trial of Azficel-T in Acne Scarring 66
09 Aug 2010 Pluristem's PLX Cells Found to Be Effective in Treating Neuropathic and Inflammatory Pain 62
05 Aug 2010 Tekmira Pharmaceuticals Files IND Application With U.S. FDA for PLK1 SNALP 53
04 Aug 2010 Excaliard Announces Positive Data From Phase 2 Clinical Trial of Its Anti-Scarring Drug, EXC 001 63
03 Aug 2010 Antisense Pharma Obtains IND for Clinical Studies in the USA 102
02 Aug 2010 BioVex Announces Publication of Head and Neck Cancer Clinical Trial Results with OncoVEX GM-CSF in the Journal Clinical Cancer Research 101
31 Jul 2010 Geron to Proceed with First Human Clinical Trial of Embryonic Stem Cell-Based Therapy 88
29 Jul 2010 Bio-Path Holdings Announces Dosing of First Patient in a Phase I Clinical Trial of Its Liposomal Grb-2 Cancer Drug Candidate 75
28 Jul 2010 Athersys Announces Positive Results from Phase I Study of Multistem(R) in Heart Attack Patients 65
27 Jul 2010 SurModics and EGEN Announce Collaboration with Potential for Long-term Delivery of siRNA 23
27 Jul 2010 Exact Sciences Obtains Exclusive License to OncoMethylome Sciences' DNA Methylation Biomarkers 69
21 Jul 2010 Prochymal New Drug Submission Granted Priority Review by Health Canada 88
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 1 - 30 of 1103

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Tau and Amyloid Beta Targeted Therapy of Alzheimer’s Disease

Order Now

Recommended Report

R&D Drug Pipeline Database
Order Now

Subscribe La Merie Biologics